SCHEMBL2140805

SCHEMBL2140805

C=CC(=O)NC(C)C[N+](C)(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.54
CHRM2 P08172 2/20 0.39
CHRM4 P08173 2/20 0.39
CHRM1 P11229 2/20 0.39
TBXA2R P21731 1/20 0.39
MAPT P10636 3/20 0.38
GALR3 O60755 1/20 0.38
BLM P54132 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CRAT P43155 1/20 0.38
ACACB O00763 2/20 0.38
ALDH1A1 P00352 2/20 0.37
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
LMNA P02545 2/20 0.34
CHRM5 P08912 1/20 0.34
CHRM3 P20309 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.33
ZDHHC20 Q5W0Z9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL31228205 0.98 TSHR (0.52) TSHRCHRM2CHRM4CHRM1TBXA2R
Hydrochloric Acid SCHEMBL1483412 0.98 TSHR (0.52) TSHRCHRM2CHRM4CHRM1TBXA2R
Sulfuric Acid SCHEMBL31228173 0.91 TSHR (0.46) TSHRCHRM2CHRM4CHRM1TBXA2R
SCHEMBL6116476 0.86 TSHR (0.41) TSHRCHRM2CHRM4CHRM1TBXA2R
Bromide SCHEMBL6117220 0.82 TSHR (0.47) TSHRACACBALDH1A1MAPK1TDP1
Hydrochloric Acid SCHEMBL4615371 0.82 TSHR (0.47) TSHRACACBALDH1A1MAPK1TDP1
SCHEMBL10359751 0.81 TSHR (0.50) TSHRACACBALDH1A1MAPK1TDP1
Bromide SCHEMBL6116803 0.79 TSHR (0.48) TSHRACACBALDH1A1MAPK1TDP1
Hydrochloric Acid SCHEMBL7906759 0.79 TSHR (0.48) TSHRSMN1; SMN2ACACBALDH1A1MAPK1
Hydrochloric Acid SCHEMBL6117341 0.79 TSHR (0.48) TSHRACACBALDH1A1MAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2293771-B1 NOVEL INVERSE LATICES THAT ARE FREE OF OXYETHYLENE DERIVATIVES, AND COSMETIC, DERMOCOSMETIC, DERMOPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME SOCIÉTÉ D EXPL DE PRODUITS POUR LES IND CHIMIQUES SEPPIC (FR) 2014-12-03 EP claimed
EP-2293770-B1 NOVEL INVERSE LATICES BASED ON FATTY ALCOHOL ETHERS, AND COSMETIC, DERMOCOSMETIC, DERMOPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME SOCIÉTÉ D EXPL DE PRODUITS POUR LES IND CHIMIQUES SEPPIC (FR) 2014-08-06 EP claimed
US-20120157552-A1 Novel concentrated inverse latex, process for preparing it and industrial use thereof Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) 2012-06-21 US claimed
US-20080312343-A1 Novel Concentrated Inverse Latex, Process for Preparing It and Industrial Use Thereof SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2008-12-18 US claimed
EP-1889854-A1 New terpolymer concentrated inverse latex, method of preparing same and industrial use SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES, S.E.P.P.I.C. (FR) 2008-02-20 EP claimed
US-20070219315-A1 Novel Concentrated Inverse Latex, Production Method, and use Thereof in Industry SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES (SEPPIC) (FR) 2007-09-20 US claimed
EP-3254835-B1 PRODUCTION METHOD FOR 3D MODELED OBJECT KJ CHEMICALS CORP (JP) 2021-06-16 EP disclosed
US-10286598-B2 Method for manufacturing three-dimensional molded product and three-dimensional molded product using the same KJ CHEMICALS CORPORATION (JP) 2019-05-14 US disclosed
US-20180264716-A1 METHOD FOR MANUFACTURING THREE-DIMENSIONAL MOLDED PRODUCT AND THREE-DIMENSIONAL MOLDED PRODUCT USING THE SAME KJ CHEMICALS CORPORATION (JP) 2018-09-20 US disclosed
EP-1828256-B1 NOVEL CONCENTRATED POSITIVE LATEX, METHOD FOR THE PREPARATION THEREOF, AND USE THEREOF IN INDUSTRY SEPPIC SA (FR) 2015-02-11 EP disclosed
EP-2293771-B1 NOVEL INVERSE LATICES THAT ARE FREE OF OXYETHYLENE DERIVATIVES, AND COSMETIC, DERMOCOSMETIC, DERMOPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME SOCIÉTÉ D EXPL DE PRODUITS POUR LES IND CHIMIQUES SEPPIC (FR) 2014-12-03 EP disclosed
EP-2293770-B1 NOVEL INVERSE LATICES BASED ON FATTY ALCOHOL ETHERS, AND COSMETIC, DERMOCOSMETIC, DERMOPHARMACEUTICAL OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME SOCIÉTÉ D EXPL DE PRODUITS POUR LES IND CHIMIQUES SEPPIC (FR) 2014-08-06 EP disclosed
US-8765822-B2 Concentrated inverse latex, process for preparing it and industrial use thereof SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2014-07-01 US disclosed
US-20120157552-A1 Novel concentrated inverse latex, process for preparing it and industrial use thereof Société d'Exploitation de Produits pour les Industries Chimiques SEPPIC (FR) 2012-06-21 US disclosed
US-8148433-B2 Concentrated inverse latex, process for preparing it and industrial use thereof SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES (SEPPIC) (FR) 2012-04-03 US disclosed
US-20080312343-A1 Novel Concentrated Inverse Latex, Process for Preparing It and Industrial Use Thereof SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES SEPPIC (FR) 2008-12-18 US disclosed
EP-1903060-A1 Novel concentrated inverse latex, production method and use thereof in industry SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES, S.E.P.P.I.C. (FR) 2008-03-26 EP disclosed
EP-1889854-A1 New terpolymer concentrated inverse latex, method of preparing same and industrial use SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES, S.E.P.P.I.C. (FR) 2008-02-20 EP disclosed
US-20070219315-A1 Novel Concentrated Inverse Latex, Production Method, and use Thereof in Industry SOCIETE D'EXPLOITATION DE PRODUITS POUR LES INDUSTRIES CHIMIQUES (SEPPIC) (FR) 2007-09-20 US disclosed